Lifelight and Open Telehealth (OTH.io) announced the beginning of a promising partnership that will result in the integration of Lifelight’s vital signs monitoring into OTH.io, a comprehensive and robust remote patient monitoring (RPM) platform for healthcare professionals that enables remote access to care for thousands of patients worldwide.
In the wake of the pandemic and the resulting paradigm shift in healthcare, the medical industry has turned to technological solutions to eliminate or reduce the need for physical interactions within the sphere. With telehealth becoming the norm over the past year, the optimisation of remote patient monitoring is key.
That’s where the partnership between the two healthtech leaders comes in. By integrating Lifelight’s remote vital signs capture solution with OTH.io, patients and clinicians can safely access a much more comprehensive view of the patient’s overall health. The newly integrated tool provides essential physiological data for health assessment and enables professionals to make the most appropriate clinical decisions with the unique information provided by the OTH.io platform, resulting in improved patient outcomes.
About the partners
Developed by Southampton-based technology pioneer xim Ltd, Lifelight is a highly innovative technology solution that enables contactless vital signs measurement in just 40 seconds, using a standard smartphone or tablet, without additional hardware. The technology works by detecting the tiny changes in facial skin colour that occur with each heartbeat – including heart rate, blood pressure and respiration. Lifelight is the only rPPG platform built to the rigorous ISO 13485 and IEC 62304 medical quality standards.
Danish company OTH.io, meanwhile, is also built to the ISO13485 medical standard. The Remote Care platform integrates existing IT infrastructures and offers open interfaces for seamless configurations that facilitate the needs of patients and professionals. The technology has also been proven in other industries, as its thresholding engine is capable of scaling specific RPM solutions for system integrators, enabling them to meet the needs of larger populations quickly and cost-effectively.
Speaking about the partnership, Laurence Pearce, CEO and founder of Lifelight, noted that the company is thrilled to partner with OTH.io to address the challenges of scaling remote patient monitoring, enabling more and more patients to connect with their doctors safely and remotely through an optimised telehealth platform from the comfort of their own home.
According to Laurence, this change is crucial due to the increase in demand caused by Covid-19. While phone and online consultations have become the new norm, the need for remote physical observations is still not being met. “Lifelight integrated with the OTH.io platform means that many face-to-face appointments can be reduced and, in some cases, replaced with more regular remote monitoring, providing better levels of patient care,” she explains.
Henrik L. Ibsen, CEO of OTH.io, added that the integration of Lifelight’s technology into the platform allows for a much larger number of people to be monitored at much lower costs, while allowing the platform to access a huge volume of data that will contribute to the ongoing optimisation of the RPM. He called Lifelight “a revolution in medical care, supporting the changing paradigm of telehealth and the demand for remote patient monitoring.” Indeed, Henrik went on to explain how seamless the system integration is, taking only a few days, mainly due to Lifelight’s serious approach to medical data and accuracy. The result is the delivery of a robust solution to the market.
“In addition to the expensive hardware infrastructure, Lifelight also removes the stigma of people with long-term conditions having to wear medical equipment. Patients don’t want to bother with the kit, so measurements are missed and compliance is very low. With Lifelight, we get the data in a very discreet way from the user, which reduces the barriers to getting data, which is obviously very important for remote monitoring, research and the overall health of global populations,” he concluded.